You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Waldenstroms Macroglobulinemia (WM)

Showing 1 - 25 of 270
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Waldenstrom Macroglobulinemia (WM)
  • Shingrix vaccine
  • Rochester, New York
    University of Rochester
Jan 9, 2023

Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

Active, not recruiting
Has Results
  • Waldenstrom Macroglobulinemia
  • Chiba, Japan
  • +8 more
Jan 27, 2023

Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib, Bendamustine and Rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • Changchun, China
  • +5 more
Jan 27, 2023

Waldenstrom Macroglobulinemia Trial in Hackensack (Carfilzomib, Rituximab, Dexamethasone)

Completed
Has Results
  • Waldenstrom Macroglobulinemia
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Mar 18, 2022

Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 1, 2022

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
Has Results
  • Waldenström's Macroglobulinemia (WM)
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
  • +2 more
Aug 11, 2022

Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

Not yet recruiting
  • Cancer Prevention
  • +5 more
  • Prolonged Fasting Intervention
  • EDUCATION CONTROL
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 28, 2022

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

Recruiting
  • Waldenström's Macroglobulinemia
  • Salzburg, Austria
  • +1 more
May 2, 2022

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

Active, not recruiting
Has Results
  • Waldenström Macroglobulinemia (WM)
  • Acalabrutinib (ACP-196)
  • Santa Barbara, California
  • +37 more
Mar 17, 2022

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Bortezomib, Rituximab)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 6, 2020

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • +2 more
    • (no location specified)
    Jul 18, 2023

    Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
    • +1 more
    Dec 5, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Duarte, California
    • +10 more
    Jul 14, 2022

    Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • B-Cell Lymphoproliferative Disorder
    • Boston, Massachusetts
    • +2 more
    Feb 18, 2023

    Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

    Active, not recruiting
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

    Active, not recruiting
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jun 20, 2022

    Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • Venetoclax; Rituximab
    • DRC
    • (no location specified)
    Nov 4, 2022